IP-10 has been observed to inhibit the growth of malignancies such as cervical cancer through anti-angiogenic and anti-viral mechanisms [25], while it has been observed to promote growth of malignancies such as breast cancer through the CXCR3-A receptor variant [24]. The gene discussed is CXCL10; the disease is breast cancer.